Fungi are a potential goldmine for the production of pharmaceuticals. This is shown by researchers at Chalmers University of Technology, who have developed a method for finding new antibiotics from
Tag "medical research"
Scientists from LSTM’s Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB)
University of Dundee in the UK has been awarded almost £1m to boost efforts to identify new new antibiotics to tackle bacterial infections. Antimicrobial resistance is one of the greatest
Zika virus (ZIKV), which causes Zika virus disease, is spread to people primarily through the bite of an infected Aedes aegypti or Aedes albopictus mosquito. An infected pregnant woman can pass ZIKV to her
A new study published in PLOS Medicine’s Special Issue on Dementia has found that the metabolism of omega-3 and omega-6 unsaturated fatty acids in the brain are associated with
Researchers at Trinity College Dublin have discovered a way to prevent bacteria from growing on medical devices that are implanted in the human body. The researchers state the discovery is
Actelion has received approval from the European Commission for Ledaga, a treatment to prevent the progression of a rare form of skin cancer. After being acquired by Johnson & Johnson
A French teen who was given gene therapy for sickle cell disease more than two years ago now has enough properly working red blood cells to dodge the effects of
Early-phase contract research organisation Richmond Pharmacology has opened its new research facility in London Bridge, at the site formerly known as the Guy’s Drug Research Unit. The organisation state that
Lanthio Pharma has initiated a Phase I clinical trial with its lanthipeptide candidate MOR107, which is being developed as a therapy for diabetic nephropathy. Lanthio Pharma, a Dutch subsidiary of
Modus Therapeutics has raised €3.4M to support the completion of a Phase II trial for sickle cell disease, a painful condition with no cure. Modus Therapeutics, previously Dilaforette, is developing sevuparin,
The University of Liverpool, in partnership with AKL Research and Development, will lead a clinical trial testing the potential of a new therapy for osteoarthritis (OA), the most common type
Merck & Co has terminated a Phase II/III trial testing its investigational medicine verubecestat in patients with mild to moderate Alzheimer’s disease. The move came after an external data monitoring
A new biologic agent – the most potent of its kind so far – is showing early promise as part of a potential new strategy for treating HIV. The drug,
Advertisements
